Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma in Situ 1 Breast Neoplasms 1

Interventions

dodecyl maltoside 2 Magnetic Resonance Imaging 2 Electrocardiography 2 Diphenhydramine 2 Acetaminophen 2 fludarabine phosphate 1 fludarabine 1 durvalumab 1 aldesleukin 1 Tomography, X-Ray Computed 1 Respiratory Function Tests 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Mastectomy, Subcutaneous 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Hydroxyzine 1 Histamine Antagonists 1 Granisetron 1 Droperidol 1 Doxylamine 1 Docetaxel 1 Diphenoxylate 1 Cystoscopy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma in Situ × Mastectomy, Subcutaneous × 90 days × Clear all

NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡